Amgen's cholesterol-lowering antibody Repatha is being launched in Europe ... Amgen maintains that more than 60 per cent of high-risk patients in Europe are still unable to adequately lower ...

Repatha has been approved by the European Commission for patients with hard-to-treat high cholesterol. This includes patients with hypercholesterolemia (heterozygous familial and non-familial ...

WASHINGTON (CN) — In a unanimous ruling Thursday, the Supreme Court shot down the patent case of a pharmaceutical company behind drugs that purport to lower bad cholesterol ... Earlier this year, ...